Petpace
PetPace develops AI-powered smart collars for dogs and cats that continuously monitor vital signs to detect pain, seizures, and health anomalies before visible symptoms. The company serves pet parents, veterinary clinics, and research institutions across the US, Canada, and Europe through direct, retail, and clinical channels.
- Company typePrivate
- Founded2012
- HeadquartersBurlington, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Petpace does
PetPace is a privately-held pet health technology company founded in 2012 and headquartered in Burlington, Massachusetts, with original engineering and R&D based in Shefayim, Israel. The company designs and sells an AI-powered smart collar for dogs and cats that continuously monitors vital signs (pulse, HRV, respiration, temperature), behavior (activity, sleep, posture, calories), and GPS location. A key technical differentiator is its proprietary acoustic pulse-detection method, which captures vitals through the animal's fur without shaving, paired with proprietary machine-learning models that build a per-pet baseline over a 12-week progressive learning window. AI-derived outputs include a continuous Pain Score, an Epilepsy Insights module for automatic seizure detection and pre-seizure stress detection via HRV, and a Pregnancy Monitoring program that predicts whelping timing ten days to twelve hours before labor. The platform has been clinically validated through peer-reviewed research in partnership with Tufts University, Louisiana State University, Michigan State University, and the US Department of Homeland Security.
PetPace operates a hardware-plus-subscription business model. The V3.0 collar retails for $257-$419 in the US (after promotional discounts from a $399 MSRP) with required multi-year cellular and AI subscriptions priced at $200-$500 per commit; veterinary-channel collars are priced at $343-$990 per unit with $679-$1,386/yr subscriptions. A free 24/7 AskaVet telemedicine tier is bundled into the consumer product, distinguishing PetPace from hardware-only pet fitness trackers. The Research API and the recently announced integration with Crucial Data Solutions' TrialKit eClinical platform extend the offering into pharmaceutical, biotech, and academic research, monetizing validated continuous biometric datasets for clinical trials. Patents are held or pending on the AI Pain Detection, Epilepsy Monitoring, and Pregnancy Whelping Prediction systems.
PetPace distributes through a blended go-to-market combining direct-to-consumer e-commerce (petpace.com), Amazon marketplace, and Macys.com retail with dedicated enterprise sales to veterinary clinics (including an affiliate/partner program) and research institutions. The company serves three primary customer segments: pet owners with senior or chronically ill pets, veterinarians using the collar for in-clinic and remote patient monitoring, and research institutions collecting validated continuous physiological data. Recent activity includes the V2.0 launch at CES 2025 followed by the V3.0 launch in September 2025 with integrated telemedicine, a Canadian distribution partnership with TelmyVet (December 2024), and a research-market alliance with Crucial Data Solutions (October 2025). Major industry recognition in 2024-2025 includes the IoT Breakthrough Award for Wearable Device of the Year, Cannes Lions, and a peer-reviewed iScience publication.
Petpace firmographics
Firmographics- Name
- Petpace
- Legal name
- PetPace
- Website
- https://petpace.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PetPace develops AI-powered smart collars for dogs and cats that continuously monitor vital signs to detect pain, seizures, and health anomalies before visible symptoms. The company serves pet parents, veterinary clinics, and research institutions across the US, Canada, and Europe through direct, retail, and clinical channels.
- Ownership category
- akta.pro rank
Petpace industry classification
Industry- Product category
- Pet Health Wearables
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Veterinary Services (54194)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Remote Monitoring & Connected Pet Care (Wearables, IoT, Chronic Care Programs) (HLAMAGAL)
- akta.pro secondary industries
- Veterinary Telemedicine & Virtual Care Platforms (HLAMAMAC), Pet Care & Consumer Tracking IoT (Feeders, Pet Doors, GPS Trackers) (HSAPAQAL)
Keywords
Where Petpace is headquartered
LocationHeadquarters
- HQ city
- Burlington
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Petpace business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Hardware (Smart Collar): PetPace sells its AI-powered smart collar in three sizes (Small, Medium, Large) with tiered pricing by region. US consumer collar prices range from $257-$419 after promotional discounts from $399 MSRP. Canadian collars range $343-$559. European collars range $559-$700. Veterinary collars are priced at $990 per collar for US. Revenue is one-time per device, with periodic replacement cycles.
- Subscription (Cellular Data + AI Services): Recurring subscription required for cellular data connectivity, GPS services, unlimited 24/7 vet access, near real-time vital sign monitoring, instant health alerts, and early pain detection. US subscriptions: 1-Year at $25/mo ($300 billed), 2-Year at $16.70/mo ($400 billed), 3-Year at $13.90/mo ($500 billed). Canadian subscriptions: $21.50/mo annual, $14.30/mo 2-year, $12/mo 3-year. Veterinary subscriptions: $990/yr per collar with $790/yr renewal. Subscriptions represent the primary recurring revenue stream.
- Veterinary Clinic Sales: Veterinarians and clinics purchase collars and subscriptions directly for in-clinic use (hospital monitoring, post-op recovery) or to loan to patients. Clinics can also participate in an affiliate program earning revenue per collar sold with their referral code, and offer PetPace as a billable remote monitoring service.
- Research Platform & API Access: Research institutions, pharmaceutical companies, and academic researchers purchase collar units and subscriptions for research-grade data collection, with optional API connectivity and VIP consultation services for large-scale or longitudinal studies.
- Pregnancy Monitoring Program Add-on: The Pregnancy Monitoring program is offered as a free add-on during the launch period, with potential for future monetization as a premium subscription add-on feature unlocked within the existing collar subscription.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Annual | US Consumer - 1-Year Subscription + Collar |
| Hybrid | Multi-year contract | US Consumer - 2-Year Subscription + Collar (Most Popular) |
| Hybrid | Multi-year contract | US Consumer - 3-Year Subscription + Collar (Best Value) |
| Hybrid | Annual | Canada Consumer - 1-Year Subscription + Collar |
| Hybrid | Multi-year contract | Canada Consumer - 3-Year Subscription + Collar (Best Value) |
| Hybrid | Annual | Europe Consumer - 1-Year Subscription + Collar |
| Hybrid | Multi-year contract | Europe Consumer - 3-Year Subscription + Collar (Best Value) |
| Subscription | Annual | US Veterinarian Collar + 1-Year Subscription |
| Subscription | Annual | Canada Veterinarian Collar + 1-Year Subscription |
| Subscription | Annual | Europe Veterinarian Collar + 1-Year Subscription |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels10 records
Petpace product offering
Product offeringCore offering
PetPace designs, manufactures, and sells AI-powered smart health monitoring collars (V3.0) for dogs and cats that continuously collect vital signs and biometric data via onboard sensors and process them through proprietary machine learning algorithms to deliver AI-driven pain scores, seizure detection, whelping prediction, and real-time health alerts. The collar is bundled with required cellular-data and AI-service subscriptions, plus an integrated 24/7 AskaVet telemedicine feature, and is complemented by separate veterinary and research platforms.
Product overview
PetPace offers a unified smart health monitoring ecosystem centered on the PetPace 3.0 AI-powered collar for dogs and cats. The core product tracks vital signs, activity, and GPS continuously, powered by proprietary AI that detects pain, stress, and health anomalies. The portfolio includes the Veterinary Solution (same collar with multi-patient monitoring portal), the Research API (data export platform for institutions), and module add-ons such as the AI Epilepsy Insights module, Pregnancy Monitoring program, and 24/7 Telemedicine (AskaVet). A native Apple Watch app extends wrist-based access to health data. All products share the same collar hardware and cloud analytics platform, with differentiated access tiers for pet owners, veterinarians, and researchers.
Differentiator
Problem solved
Functional benefit
Products and services
- PetPace 3.0 Smart Health Collar AI-powered wearable health monitoring collar for dogs and cats that continuously tracks vital signs (pulse, HRV, temperature, respiration), activity, sleep, posture, and GPS location, transforming data into health insights and near real-time alerts via mobile app.
- PetPace 3.0 Veterinary Solution Veterinary-specific version of the smart health collar bundled with multi-patient web portal access. Enables clinicians to remotely monitor multiple patients, view trended health data, and access comparative analysis through a browser-based dashboard.
- PetPace Apple Watch App Native Apple Watch application providing wrist-based access to pet health metrics including pulse, HRV, temperature, respiration, activity, sleep scores, GPS location, and smart notifications for early health warnings.
- PetPace Veterinarian Web Portal Browser-based web application enabling veterinarians to remotely monitor multiple pet patients, view continuous vital signs, health trends, alert history, and share data across care teams without requiring additional hardware or software installation.
- PetPace Research API Data access platform providing research institutions with API connectivity for exporting structured health datasets. Supports customizable sampling intervals, cloud-based storage, and secure portal access for longitudinal animal health studies.
- AI Epilepsy Insights Module Beta AI-powered module for automatic seizure detection and logging using smart collar technology. Detects and records seizure events with timestamps, generates visual trend reports, and provides pre-seizure stress detection for treatment evaluation.
- PetPace Pregnancy Monitoring Program AI-powered pregnancy health monitoring module that tracks vital signs throughout gestation, adjusts alerts for pregnancy-specific patterns, and predicts whelping timing 10 days to 12 hours before labor begins based on behavioral and physiological changes.
- PetPace 24/7 Telemedicine (AskaVet) Built-in telehealth feature providing 24/7 access to licensed veterinarians via chat and video consultation. Integrates pet health data directly into conversations, enabling veterinarians to view real-time vital signs during consultations.
- PetPace AI Pain Score Proprietary AI-driven pain detection system synthesizing data across pulse, HRV, respiration, posture, temperature, and activity to produce continuous objective pain indicators validated through clinical research.
Quantifiable outcome
- Detects pain and health changes before visible symptoms appear through continuous vital sign monitoring and AI analysis
- +5 more outcomes
Companies that use Petpace
Customer profileNamed customers10 records
Segments7 records
Ideal customer profiles4 records
Petpace technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature8 records
Petpace partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Crucial Data SolutionscorePetPace and Crucial Data Solutions formed a strategic alliance to integrate PetPace's smart wearable health monitoring collars with CDS's TrialKit eClinical platform for veterinary and translational research. The combined solution enables real-time, objective animal health data collection from pets in their home environments, reducing stress-induced variability and improving data fidelity. The integration is immediately available for new and ongoing studies using the TrialKit platform, targeting pharmaceutical companies and academic research institutions conducting clinical trials with companion animals.
- ECAD (Educated Canines Assisting with Disabilities)minorECAD, an Assistance Dog International accredited organization, participated in a joint study with Pet Acoustics using PetPace's AI-powered smart collar to measure the effects of music on dog stress levels. Twelve service dogs from ECAD were monitored during the research, which was published in the International Animal Health Journal.
- AskaVet (Integrated Telemedicine Provider)corePetPace V3.0 integrates free 24/7 veterinary telehealth access through the AskaVet feature, enabling pet parents to chat and video conference with licensed veterinarians directly within the PetPace app. Vets can view the pet's live collar data during consultations, providing clinical context for telemedicine sessions.
- Pet AcousticscorePetPace and Pet Acoustics conducted joint research using PetPace's AI-powered smart collar to measure the effects of music on dog stress levels. The study found that Pet Acoustics' canine-specific music reduced stress and anxiety more effectively than classical music or silence, validated by PetPace collar data (HRV, pulse rates, activity levels). Findings were published as a cover story in the International Animal Health Journal. PetPace also appeared on Pet Acoustics' 'Paw-some Ways to Better Pet Health' podcast as a co-presenter.
- Michigan State UniversitycoreMichigan State University researchers used PetPace smart collars in a peer-reviewed study published in iScience, demonstrating that simple lighting changes (particularly dim blue-depleted light) dramatically reduce stress in shelter cats. The 101-cat study relied on PetPace collars to provide continuous, non-invasive monitoring of locomotor activity and circadian patterns. PetPace highlighted the study as validation of their AI-powered monitoring technology for clinical research and animal welfare applications.
- TelmyVetcorePetPace partnered with TelmyVet, a Canadian telemedicine platform for veterinary practices, to deliver advanced health monitoring collars and virtual care services to Canadian pet parents and veterinarians. The PetPace smart collar measures vital signs, mobility, behavior, and location data, which can be shared with veterinary teams through TelmyVet's platform for telemedicine consultations. A cat smart collar was expected to be released in early 2025 as part of the partnership. This partnership specifically targets the Canadian veterinary telemedicine market.
- Tufts University, Louisiana State University (LSU), U.S. Department of Homeland SecuritycorePetPace collar data has been validated in academic and government research settings including Tufts University, LSU, and the U.S. Department of Homeland Security studies, ensuring reliable data quality meeting clinical and research standards. These institutional validation studies are cited as evidence of the collar's accuracy and reliability.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Petpace competitors and assessment
Company assessmentMarket position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Petpace social profiles
Digital presencePetpace financial estimates
Financial estimateRevenue estimate
Valuation estimate
Petpace leadership team
Management profileNumber of profiles
Profiles3 records
Petpace funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Petpace M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Petpace
What does Petpace do?
PetPace designs, manufactures, and sells AI-powered smart health monitoring collars (V3.0) for dogs and cats that continuously collect vital signs and biometric data via onboard sensors and process them through proprietary machine learning algorithms to deliver AI-driven pain scores, seizure detection, whelping prediction, and real-time health alerts. The collar is bundled with required cellular-data and AI-service subscriptions, plus an integrated 24/7 AskaVet telemedicine feature, and is complemented by separate veterinary and research platforms.
Is Petpace a public or private company?
Petpace is a private company. It is classified as venture growth investor backed and is currently operating.
When was Petpace founded?
Petpace was founded in 2012. It employs 1 to 10 people.
Where is Petpace based?
Petpace is headquartered in Burlington, United States, in the North America region.
How does Petpace make money?
Five revenue lines are on record. Hardware (Smart Collar) is the primary driver. The others are subscription (Cellular Data + AI Services), veterinary Clinic Sales, research Platform & API Access and pregnancy Monitoring Program Add-on.
Does Petpace have an API?
Yes. PetPace offers API connectivity for research institutions requiring export-ready structured datasets. The API provides secure access to continuous health data including temperature, pulse rate, respiration, HRV, activity, posture, calories, and location data collected from dogs and cats wearing the monitoring collars. Researchers can access raw data review, customizable sampling intervals, and cloud-based storage through a secure portal. Developer documentation is at petpace.com/researchers.
What industry is Petpace in?
Petpace's product category is Pet Health Wearables. Its primary akta.pro industry code is HLAMAGAL, Remote Monitoring & Connected Pet Care (Wearables, IoT, Chronic Care Programs), with a secondary code of HLAMAMAC, Veterinary Telemedicine & Virtual Care Platforms. Its NAICS code is 334510 and its SIC code is 3845.